Tokyo, Nov. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063337) titled 'Observational Study on the Efficacy and Safety of Ultrahypofractionated Whole-Breast Irradiation after Breast-Conserving Surgery' on Nov. 16.

Study Type: Observational

Primary Sponsor: Institute - St. Luke's International University, St. Luke's International Hospital

Condition: Condition - Breast Cancer Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - To prospectively investigate the outcomes of ultrahypofractionated whole-breast irradiation in patients following breast-conserving surgery and to clarify its efficacy and safety. Basic objectives2 - Safety,Efficacy

Eligibility: Age-lower limit - 20 years-old

Gender - Female Key inclusion criteria - Patients with breast cancer who have undergone breast-conserving surgery at our institution and are deemed candidates for whole-breast irradiation without indication for postoperative regional nodal irradiation. Key exclusion criteria - Patients currently undergoing treatment for another malignancy. Target Size - 120

Recruitment Status: Recruitment status - Enrolling by invitation Date of protocol fixation - 2026 Year 10 Month 19 Day Date of IRB - 2026 Year 10 Month 19 Day Anticipated trial start date - 2026 Year 11 Month 16 Day Last follow-up date - 2031 Year 07 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072494

Disclaimer: Curated by HT Syndication.